Recently, a committed non-profit organization known as Doctors Without Borders/Médecins Sans Frontières (MSF) issued a call for more transparency in clinical research. […]
The Institute for Clinical and Economic Review (ICER) today published its latest report on Unsupported Price Increases (UPI) of prescription […]
Not widely known outside of drug pricing policy and business experts, the Boston-based nonprofit organization known as the Institute for […]
Danish drug maker Novo Nordisk, a leading producer of diabetes drugs, recently announced it extended its COVID-19 Patient Assistance Program […]
On Oct. 9, TrialSite reported Eli Lilly could be on the verge of securing an emergency use authorization (EUA) from the […]
Sao Paulo state government in Brazil has requested from Brazil’s national health regulator, Anvisa, to register CoronaVac, the vaccine candidate developed […]
Congress’ Committee on Oversight and Reform recently detailed a sweeping investigation into “skyrocketing prices of prescription drugs.” The Congressional Committee zeroed […]
Doctors are prescribing ever more numbers of favipiravir-based drugs for patients with mild COVID-19 as it actually becomes India’s top […]
Picking up on the ongoing “Family Man” saga, in New York Court, EGT claims that Zynteglo, the Bluebird Bio product […]
Adar Poonawalla leads perhaps the busiest vaccine production operation in the world. The billionaire and CEO of Serum Institute of India (SII) […]
